Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Garcia-Sastre Laboratory 

icahn.mssm.edu   /   Inside Mount Sinai Blog

Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Thomas Kehrer

Ph.D. Student
thomas.kehrer@icahn.mssm.edu

RSS Recent Publications

  • Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models August 8, 2022 Aryana Javaheri
  • Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza July 22, 2022 Sira C Günther
  • Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA July 9, 2022 Sunnie M Yoh
  • Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera July 7, 2022 Raveen Rathnasinghe
  • Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples July 1, 2022 Alba Escalera
  • Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity June 29, 2022 Marie O Pohl
  • Nuclear speckle integrity and function require TAO2 kinase June 15, 2022 Shengyan Gao
  • Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice June 6, 2022 Irene González-Domínguez
  • Type I and Type II Interferon Antagonism Strategies Used by <em>Paramyxoviridae</em>: Previous and New Discoveries, in Comparison May 28, 2022 Giuseppe Pisanelli
  • Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine May 18, 2022 Aitor Nogales
  • Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam May 16, 2022 Anh Duc Dang
  • Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer May 3, 2022 Philip C Mack
  • Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial April 24, 2022 Nicolas Folschweiller
  • Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge April 23, 2022 Alaa Mabrouk Salem Omar
  • Defining the risk of SARS-CoV-2 variants on immune protection April 1, 2022 Marciela M DeGrace

Upcoming Events

Click here to view a calendar with upcoming events.

Careers | Contact Us | Privacy | Legal
800-MD-SINAI
© Icahn School of Medicine at Mount Sinai